Testing effectiveness (Phase 2)Study completedNCT01696474
What this trial is testing
Short Course of Bortezomib in Anemic Patients With Refractory Cold Agglutinin Disease
Who this might be right for
Refractory Cold Agglutinin Disease
Gruppo Italiano Malattie EMatologiche dell'Adulto 21